Medulloblastoma
Cancer research center reports that retinoids kill childhood brain tumor cells
Published in Drug Week, September 5th, 2003
Researchers find that vitamin A derivatives may be highly effective and minimally toxic treatments for medulloblastoma, the most common form of childhood brain cancer. Clinical trials of the drugs, known as retinoids, are being planned for children who are at high risk for tumor relapse following standard therapy.
A study led by Fred Hutchinson Cancer Research Center researchers, Drs. Andrew Hallahan and James Olson, showed that...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2003-09-05)
More Articles from Drug Week
- Antibiotic Resistance
Newly discovered inhibitors of bacterial lactamases may prevent resistance - Pain Medicine
Compound that acts on peripheral receptors may be promising treatment - Atherosclerosis
Patient enrollment completed in phase IIb CART-2 study with AGI-1067 - Breast Cancer
Trial tests treatment for postmenopausal cancer patients who relapse - Drug Development
PEDF could potentially treat a variety of angiogenesis-related disorders - Myocardial Infarction
Antidepressant reduces clotting factors after heart attack - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
